PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Sjögren's drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called IBI355 in 30 adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal was to check the drug's safety and how the body processes it. Researchers gave multiple doses to see if it coul…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
New drug shows promise for Sjögren's sufferers in extended safety trial
Disease control CompletedThis study looks at the long-term safety of a drug called efgartigimod for adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants had already completed a previous efgartigimod study. The drug works by lowering harmful antibodies…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 18, 2026 12:00 UTC